To earn trust, every day.
Adobe Flash Player version 9 (or greater) is required to view this banner. Click here to install the latest version of Flash.
Human Prescription - Cardiovascular Disease - Central Nervous System - Anesthesia - Immunology and Infectious Diseases - Oncology - Respiratory - Women's Health
Animal Health
Consumer Health Care
November 24, 2008Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
November 24, 2008Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
November 24, 2008Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease
November 24, 2008Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
November 7, 2008Schering-Plough to Webcast R&D Update Meeting
November 1, 2008Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:
